Dean E. Schraufnagel

Author

Also Known As

Carrie Kujoth, D E Schraufnagel, D Schraufnagel, D. E. Schraufnagel, D. Schraufnagel, D.E. Schraufnagel, DE Schraufnagel, DEAN E. SCHRAUFNAGEL, Dean E Schraufnagel, Dean E. Schraufnagel

215

Publications

12.9K

Citations

H-Index

160

Concepts

All Affiliations

University of Illinois Chicago Johns Hopkins University University of Illinois Urbana-Champaign University of California, Los Angeles Medical University of South Carolina

About

Dean E. Schraufnagel is an author at University of Illinois Chicago specializing in medicine, health sciences, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	37	3.8K
2	Health Sciences	12	12	812
3	Public Health	11	11	1.6K
4	Engineering	2	2	50
5	Natural Sciences	1	1	23

Dean E. Schraufnagel

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Cyclophosphamide versus Placebo in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, New England Journal of Medicine	2006	1.6K
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial Donald P. Tashkin, Michael D. Roth, Philip J. Clements, The Lancet Respiratory Medicine Sls IiMycophenolate MofetilInflammatory Lung DiseaseAdvanced Lung DiseaseSystemic Scleroderma	2016	1K
The Global Burden of Respiratory Disease Thomas Ferkol, Dean E. Schraufnagel Annals of the American Thoracic Society AsthmaPulmonary CareRespiratory DiseaseEnvironmental HealthRespiratory Infection	2014	703
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, American Journal of Respiratory and Critical Care Medicine	2007	463
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity Roberto F. Machado, Robyn J. Barst, Nancy A. Yovetich, Blood	2011	245
Racial Difference in Sarcoidosis Mortality in the United States Mehdi Mirsaeidi, Roberto F. Machado, Dean E. Schraufnagel, CHEST Journal Sarcoidosis MortalityHealth DisparitiesSocial Determinants Of HealthPublic HealthRacial Disparities	2014	244
High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease Jonathan Goldin, David A. Lynch, Diane C. Strollo, CHEST Journal Medical ImagingAdvanced Lung DiseaseSystemic SclerodermaDiagnosisPathology	2008	239
TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation Mohammad Tauseef, Nebojša Nick Knežević, Koteswara R. Chava, The Journal of Experimental Medicine	2012	231
Treatment of Tuberculosis. A Historical Perspective John F. Murray, Dean E. Schraufnagel, Philip C. Hopewell Annals of the American Thoracic Society Tuberculosis PreventionA Historical PerspectivePharmacotherapyAntimicrobial ChemotherapyDrug Resistance	2015	229
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe Mehdi Nouraie, Janet Lee, Yingze Zhang, Haematologica	2012	217

Page 1